AURITEC PHARMACEUTICALS, INC. SBIR Phase II Award, July 2022
A SBIR Phase II contract was awarded to Auritec Pharmaceuticals, Inc in July, 2022 for $1,024,014.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Currently, there are no issues on this topic.
Find more entities like AURITEC PHARMACEUTICALS, INC. SBIR Phase II Award, July 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.